Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 3.05k | 77.90% |
| Gross profit | -13.41k | 261.58% |
| Net profit | -596.32k | 58.91% |
| EBITDA | -592.69k | 33.17% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.93m |
Number of shares | 227.04m |
52-week high/low | €0.0308 - €0.00852 |
| Dividends | No |
Beta | 1.53 |
P/E ratio | -0.32 |
PEG ratio | 0.00 |
P/B ratio | -0.18 |
P/S ratio | 20.51 |
Company profile
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.
| Name | NuGen Medical Devices |
| CEO | Lin Liang |
| Headquarters | Toronto,
on Canada |
| Website | |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| IPO | 25/02/2022 |
| Employees | 5 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | NGMDF |
Frankfurt | 79O.F |
Düsseldorf | 79O.DU |
München | 79O.MU |
